Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Sell
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
ImmunityBio, Inc. Common Stock (IBRX)
Biological Products, (no Disgnostic Substances)
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.
3530 JOHN HOPKINS COURT
SAN DIEGO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
03/10/2021
Market Cap
2,820,958,650
Shares Outstanding
667,710,000
Weighted SO
670,331,089
Total Employees
N/A
Upcoming Earnings
08/13/2024
Similar Tickers
Beta
-0.3110
Last Div
0.0000
Range
1.25-10.53
Chg
0.0700
Avg Vol
3368937
Mkt Cap
2820958650
Exch
NASDAQ
Country
US
Phone
858 633 0300
DCF Diff
5.2927
DCF
-1.2590
Div Yield
0.0000
P/S
2156.6962
EV Multiple
-10.5408
P/FV
-3.9836
Div Yield %
0.0000
P/E
-4.6551
PEG
-2.4659
Payout
0.0000
Current Ratio
3.9097
Quick Ratio
3.8805
Cash Ratio
2.0947
DSO
574.8471
DIO
36.5000
Op Cycle
611.3471
DPO
409.4812
CCC
201.8659
Gross Margin
-12.8456
Op Margin
-274.5933
Pretax Margin
-456.9801
Net Margin
-456.9167
Eff Tax Rate
0.0151
ROA
-1.3451
ROE
1.0006
ROCE
-0.9397
NI/EBT
0.9999
EBT/EBIT
1.6642
EBIT/Rev
-274.5933
Debt Ratio
2.1663
D/E
-1.3782
LT Debt/Cap
3.7083
Total Debt/Cap
3.6440
Int Coverage
-74.8579
CF/Debt
-0.4046
Equity Multi
-0.6362
Rec Turnover
0.6350
Pay Turnover
0.8914
Inv Turnover
10.0000
FA Turnover
0.0074
Asset Turnover
0.0029
OCF/Share
-0.5669
FCF/Share
-0.6010
Cash/Share
0.3173
OCF/Sales
-297.7309
FCF/OCF
1.0601
CF Coverage
-0.4046
ST Coverage
-62.1005
CapEx Coverage
-16.6303
Div&CapEx Cov
-16.6303
P/BV
-3.9836
P/B
-3.9836
P/S
2156.6962
P/E
-4.6551
P/FCF
-6.8329
P/OCF
-7.1440
P/CF
-7.1440
PEG
-2.4659
P/S
2156.6962
EV Multiple
-10.5408
P/FV
-3.9836
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
465.80K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
4.64M Shares Bought (92.98 %)
349.72K Shares Sold (7.02%)
6 - 9 Months
85.91K Shares Bought (43.08 %)
113.52K Shares Sold (56.92%)
9 - 12 Months
209.77M Shares Bought (99.92 %)
160.82K Shares Sold (0.08 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 7.00K | ▲ 9.00K | ▼ -147.00K | ▲ 390.00K | ▼ 73.00K | ▲ 139.00K | ▼ 40.00K |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 6.88M | ▼ 4.56M | ▼ 4.56M |
Gross Profit | 7.00K | ▲ 9.00K | ▼ -147.00K | ▲ 390.00K | ▼ -6.81M | ▲ -4.43M | ▼ -4.52M |
Gross Profit Ratio | 1.00 | 1.00 | 1.00 | 1.00 | ▼ -93.22 | ▲ -31.83 | ▼ -100.00 |
Research And Development Expenses | 12.48M | ▼ 12.00M | ▲ 43.36M | ▲ 51.75M | ▲ 58.08M | ▼ 51.03M | ▲ 52.85M |
General And Administrative Expenses | 5.25M | ▼ 4.12M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 5.25M | ▼ 4.12M | ▲ 23.88M | ▲ 27.91M | ▼ 26.22M | ▲ 29.05M | ▲ 37.83M |
Other Expenses | 0.00 | 0.00 | ▲ 217.00K | ▼ -59.00K | ▼ -923.00K | ▼ -37.02M | ▲ -20.00K |
Operating Expenses | 17.73M | ▼ 16.12M | ▲ 67.24M | ▲ 79.66M | ▲ 84.29M | ▼ 80.08M | ▲ 90.68M |
Cost And Expenses | 17.73M | ▼ 16.12M | ▲ 67.24M | ▲ 79.66M | ▲ 84.29M | ▲ 84.64M | ▲ 95.24M |
Interest Income | 0.00 | 0.00 | ▲ 526.00K | ▼ 284.00K | ▲ 515.00K | ▲ 1.84M | ▼ 160.00K |
Interest Expense | 145.00K | ▼ 11.00K | ▲ 2.84M | ▲ 4.49M | ▲ 28.56M | ▲ 32.13M | ▲ 37.49M |
Depreciation And Amortization | 2.79M | ▼ 2.21M | ▲ 2.23M | ▲ 3.60M | ▼ 1.97M | ▲ 4.56M | ▼ 4.56M |
Ebitda | -14.54M | ▲ -13.48M | ▼ -64.80M | ▼ -76.46M | ▼ -82.93M | ▲ -79.94M | ▼ -90.64M |
Ebitda Ratio | -100.00 | -100.00 | ▲ 100.00 | ▼ -100.00 | -100.00 | -100.00 | -100.00 |
Operating Income | -17.32M | ▲ -15.69M | ▼ -67.39M | ▼ -79.27M | ▼ -84.90M | ▲ -84.50M | ▼ -95.20M |
Operating Income Ratio | -1,000.00 | -1,000.00 | ▲ 458.40 | ▼ -203.27 | ▼ -1,000.00 | ▲ -607.94 | ▼ -1,000.00 |
Total Other Income Expenses Net | -145.00K | ▲ -11.00K | ▲ 913.00K | ▼ -8.07M | ▼ -23.39M | ▼ -148.95M | ▲ -38.93M |
Income Before Tax | -17.47M | ▲ -15.70M | ▼ -68.78M | ▼ -91.55M | ▼ -108.29M | ▼ -233.45M | ▲ -134.13M |
Income Before Tax Ratio | -100.00 | -100.00 | ▲ 100.00 | ▼ -100.00 | -100.00 | -100.00 | -100.00 |
Income Tax Expense | -128.00K | ▲ -63.00K | ▼ -209.00K | ▲ 1.00K | ▲ 34.00K | ▼ -40.00K | ▲ -21.00K |
Net Income | -17.34M | ▲ -15.64M | ▼ -67.77M | ▼ -91.26M | ▼ -108.33M | ▼ -233.39M | ▲ -134.11M |
Net Income Ratio | -100.00 | -100.00 | ▲ 100.00 | ▼ -100.00 | -100.00 | -100.00 | -100.00 |
Eps | -0.05 | ▲ -0.04 | ▼ -0.18 | ▼ -0.23 | ▼ -0.27 | ▼ -0.35 | ▲ -0.20 |
Eps Diluted | -0.05 | ▲ -0.04 | ▼ -0.18 | ▼ -0.23 | ▼ -0.27 | ▼ -0.35 | ▲ -0.20 |
Weighted Average Shs Out | 325.05M | ▲ 393.89M | ▼ 383.18M | ▲ 397.12M | ▲ 403.64M | ▲ 670.87M | ▲ 672.83M |
Weighted Average Shs Out Dil | 325.05M | ▲ 393.89M | ▼ 383.18M | ▲ 397.12M | ▲ 403.64M | ▲ 670.87M | ▲ 672.83M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 16.82M | ▼ 15.51M | ▲ 34.92M | ▲ 181.10M | ▼ 104.64M | ▲ 265.45M | ▼ 133.04M |
Short Term Investments | 57.33M | ▼ 36.14M | ▲ 61.15M | ▲ 136.02M | ▼ 2.54M | ▼ 1.01M | ▲ 37.46M |
Cash And Short Term Investments | 74.15M | ▼ 51.65M | ▲ 96.06M | ▲ 317.12M | ▼ 107.18M | ▲ 266.46M | ▼ 170.50M |
Net Receivables | 12.17M | ▼ 303.00K | ▲ 2.00M | ▼ 1.33M | ▲ 1.89M | ▲ 3.17M | ▼ 2.14M |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 26.35M | ▼ 0.00 | 0.00 |
Other Current Assets | 2.46M | ▲ 3.80M | ▲ 13.65M | ▲ 15.90M | ▼ 5.15M | ▲ 24.45M | ▼ 23.09M |
Total Current Assets | 88.77M | ▼ 55.76M | ▲ 111.71M | ▲ 334.35M | ▼ 140.58M | ▲ 294.08M | ▼ 195.72M |
Property Plant Equipment Net | 76.89M | ▼ 72.23M | ▲ 90.68M | ▲ 119.17M | ▲ 189.45M | ▼ 182.68M | ▼ 178.75M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 565.00K | ▼ 0.00 | ▲ 1.46M | ▼ 1.42M | ▲ 20.00M | ▼ 17.09M | ▼ 16.57M |
Goodwill And Intangible Assets | 565.00K | ▼ 0.00 | ▲ 1.46M | ▼ 1.42M | ▲ 20.00M | ▼ 17.09M | ▼ 16.57M |
Long Term Investments | 0.00 | ▲ 9.25M | ▲ 10.45M | ▼ 6.78M | ▼ 5.70M | ▲ 8.10M | ▼ 6.94M |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ -1.00 |
Other Non Current Assets | 15.73M | ▼ 5.88M | ▲ 7.08M | ▲ 7.20M | ▼ 6.63M | ▼ 2.49M | ▲ 2.69M |
Total Non Current Assets | 93.18M | ▼ 87.37M | ▲ 109.67M | ▲ 134.56M | ▲ 221.78M | ▼ 210.37M | ▼ 204.96M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 181.95M | ▼ 143.12M | ▲ 221.38M | ▲ 468.91M | ▼ 362.36M | ▲ 504.45M | ▼ 400.68M |
Account Payables | 2.79M | ▼ 1.75M | ▲ 11.51M | ▼ 11.42M | ▲ 21.02M | ▼ 9.20M | ▲ 13.87M |
Short Term Debt | 0.00 | 0.00 | ▲ 5.02M | ▲ 302.25M | ▲ 434.55M | ▼ 6.78M | ▼ 6.72M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 100.00K | 100.00K | 100.00K |
Other Current Liabilities | 24.47M | ▼ 9.81M | ▲ 51.61M | ▲ 55.33M | ▼ 45.19M | ▼ 42.21M | ▼ 33.07M |
Total Current Liabilities | 27.26M | ▼ 11.56M | ▲ 68.13M | ▲ 369.00M | ▲ 500.86M | ▼ 58.28M | ▼ 53.76M |
Long Term Debt | 0.00 | ▲ 10.89M | ▲ 270.53M | ▲ 343.42M | ▼ 289.22M | ▲ 836.95M | ▲ 850.50M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | ▲ 170.00K | ▼ 162.00K | ▼ 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 8.68M | ▼ 0.00 | ▲ 1.04M | ▼ 249.00K | ▲ 22.09M | ▲ 195.15M | ▼ 187.40M |
Total Non Current Liabilities | 8.68M | ▲ 10.89M | ▲ 271.74M | ▲ 343.83M | ▼ 311.32M | ▲ 1.03B | ▲ 1.04B |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | ▲ 10.89M | ▲ 21.19M | ▲ 40.08M | ▲ 50.60M | ▼ 39.94M | ▼ 38.20M |
Total Liabilities | 35.94M | ▼ 22.44M | ▲ 339.87M | ▲ 712.82M | ▲ 812.18M | ▲ 1.09B | ▲ 1.09B |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 8.00K | ▲ 10.00K | ▲ 38.00K | ▲ 40.00K | ▲ 42.00K | ▲ 67.00K | ▲ 68.00K |
Retained Earnings | -594.98M | ▼ -662.19M | ▼ -1.62B | ▼ -1.96B | ▼ -2.38B | ▼ -2.96B | ▼ -3.10B |
Accumulated Other Comprehensive Income Loss | -11.56M | ▼ -18.61M | ▲ 122.00K | ▼ 4.00K | ▲ 183.00K | ▼ 10.00K | ▼ -7.00K |
Other Total Stockholders Equity | 752.54M | ▲ 801.47M | ▲ 1.50B | ▲ 1.72B | ▲ 1.93B | ▲ 2.37B | ▲ 2.40B |
Total Stockholders Equity | 146.01M | ▼ 120.68M | ▼ -119.81M | ▼ -242.17M | ▼ -447.33M | ▼ -586.99M | ▼ -692.01M |
Total Equity | 146.01M | ▼ 120.68M | ▼ -119.81M | ▼ -242.17M | ▼ -449.82M | ▼ -585.94M | ▼ -690.98M |
Total Liabilities And Stockholders Equity | 181.95M | ▼ 143.12M | ▲ 221.38M | ▲ 468.91M | ▼ 362.36M | ▲ 504.45M | ▼ 400.68M |
Minority Interest | 0.00 | 0.00 | ▲ 1.32M | ▼ -1.74M | ▼ -2.49M | ▲ 1.05M | ▼ 1.03M |
Total Liabilities And Total Equity | 181.95M | ▼ 143.12M | ▲ 221.38M | ▲ 468.91M | ▼ 362.36M | ▲ 504.45M | ▼ 400.68M |
Total Investments | 57.33M | ▼ 45.40M | ▲ 71.59M | ▲ 142.79M | ▼ 8.24M | ▲ 9.11M | ▲ 44.40M |
Total Debt | 6.91M | ▲ 14.85M | ▲ 275.55M | ▲ 645.66M | ▲ 723.77M | ▲ 883.68M | ▲ 895.42M |
Net Debt | -9.91M | ▲ -660.00K | ▲ 240.63M | ▲ 464.56M | ▲ 619.13M | ▼ 618.22M | ▲ 762.39M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -17.34M | ▲ -15.64M | ▼ -68.57M | ▼ -91.55M | ▼ -108.33M | ▼ -233.39M | ▲ -134.11M |
Depreciation And Amortization | 2.79M | ▼ 2.21M | ▲ 2.23M | ▲ 3.60M | ▲ 5.23M | ▼ 4.56M | ▼ 4.56M |
Deferred Income Tax | -122.00K | ▲ 0.00 | ▼ -207.00K | ▲ -8.00K | ▲ -4.00K | ▼ -24.78M | ▲ 0.00 |
Stock Based Compensation | 1.41M | ▼ 477.00K | ▲ 671.00K | ▲ 10.18M | ▼ 9.35M | ▲ 12.77M | ▼ 8.27M |
Change In Working Capital | -8.65M | ▼ -14.90M | ▲ 3.08M | ▼ -6.79M | ▲ -6.59M | ▼ -25.75M | ▲ -3.89M |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | -1.03M | ▲ -301.00K | ▼ -4.71M | ▲ -3.55M | ▲ 437.00K | ▼ -2.88M | ▲ 4.31M |
Other Working Capital | -7.62M | ▼ -14.60M | ▲ 7.79M | ▼ -3.24M | ▼ -7.03M | ▼ -22.87M | ▲ -8.21M |
Other Non Cash Items | 7.89M | ▲ 12.97M | ▼ 5.20M | ▲ 12.93M | ▼ 9.62M | ▲ 151.31M | ▼ 31.26M |
Net Cash Provided By Operating Activities | -14.03M | ▼ -14.89M | ▼ -57.60M | ▼ -71.64M | ▼ -90.73M | ▼ -115.27M | ▲ -106.99M |
Investments In Property Plant And Equipment | -2.05M | ▲ -680.00K | ▲ 699.00K | ▼ -10.40M | ▼ -18.93M | ▲ -7.96M | ▲ -1.26M |
Acquisitions Net | 0.00 | 0.00 | ▲ 8.00K | ▼ 0.00 | ▲ 1.00M | ▼ -10.20M | ▲ 0.00 |
Purchases Of Investments | -12.51M | ▲ -9.79M | ▲ -6.11M | ▼ -139.00M | ▲ -19.00K | ▼ -166.00K | ▼ -48.36M |
Sales Maturities Of Investments | 30.08M | ▼ 22.63M | ▼ 12.96M | ▼ 11.60M | ▼ 56.00K | ▲ 10.37M | ▲ 14.00M |
Other Investing Activities | 392.00K | ▼ 0.00 | ▼ -8.00K | ▲ 0.00 | ▼ -1.00M | ▲ 10.20M | ▼ -34.36M |
Net Cash Used For Investing Activities | 15.91M | ▼ 12.16M | ▼ 7.55M | ▼ -137.80M | ▲ -18.89M | ▲ 2.25M | ▼ -35.62M |
Debt Repayment | -142.00K | ▲ 0.00 | 0.00 | 0.00 | ▼ -18.00K | ▼ -192.74M | ▲ -21.00K |
Common Stock Issued | 57.00K | ▼ 0.00 | ▲ 1.69M | ▲ 27.58M | ▲ 60.43M | ▼ 9.36M | ▲ 14.12M |
Common Stock Repurchased | -228.00K | ▲ 0.00 | 0.00 | 0.00 | ▼ -219.00K | ▼ -1.56M | ▼ -3.87M |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -57.00K | ▼ -61.00K | ▼ -1.45M | ▲ 298.37M | ▼ 49.97M | ▲ 383.93M | ▼ -3.87M |
Net Cash Used Provided By Financing Activities | -370.00K | ▲ -61.00K | ▲ 241.00K | ▲ 325.95M | ▼ 109.94M | ▲ 200.54M | ▼ 10.23M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | ▲ 48.00K | ▲ 65.00K | ▲ 161.00K | ▼ -27.00K | ▼ -39.00K |
Net Change In Cash | 1.51M | ▼ -2.78M | ▼ -49.77M | ▲ 116.58M | ▼ 480.00K | ▲ 87.49M | ▼ -132.42M |
Cash At End Of Period | 17.00M | ▼ 15.69M | ▲ 35.09M | ▲ 181.28M | ▼ 104.97M | ▲ 265.45M | ▼ 133.04M |
Cash At Beginning Of Period | 15.49M | ▲ 18.47M | ▲ 84.86M | ▼ 64.70M | ▲ 104.49M | ▲ 177.96M | ▲ 265.45M |
Operating Cash Flow | -14.03M | ▼ -14.89M | ▼ -57.60M | ▼ -71.64M | ▼ -90.73M | ▼ -115.27M | ▲ -106.99M |
Capital Expenditure | -2.05M | ▲ -680.00K | ▲ 699.00K | ▼ -10.40M | ▼ -18.93M | ▲ -7.96M | ▲ -1.26M |
Free Cash Flow | -16.08M | ▲ -15.57M | ▼ -56.91M | ▼ -82.04M | ▼ -109.66M | ▼ -123.23M | ▲ -108.25M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)